Sensera Limited (Sensera) (ASX:SE1) is announcing the consolidation of management responsibilities in the company to streamline the leadership group and reduce costs. Ralph Schmitt the Managing Director has transitioned to an Executive Director role on the board. Tim Stucchi has been promoted to Chief Operating Officer (COO). Tim has been operating as the General Manager of the MicroDevices business since Sensera’s IPO and has been responsible for the day-to-day business activities.

Mr. Schmitt will continue to operate in an active leadership role and partner with Mr. Stucchi in his expanded responsibilities. Since the sale of the IOT Solutions business, Sensera has become more strategically focused on developing Micro Electro Mechanical Systems (MEMS) based sensors. Tim has been running MEMS based manufacturing businesses for over two decades and is well suited to continue the progression of Sensera’s business to a high-volume manufacturing company. For over a decade Mr. Stucchi was CEO of Advanced MicroSensors and built the business to shipping over 100 million sensors. He has extensive MEMS manufacturing background and has worked with numerous companies as a consultant including Sensera’s fab partner Agiltron, making him uniquely qualified to lead the company.

Renumeration for Mr. Schmitt will change from an employee based annualized US$300,000 base salary plus bonus and other employee benefits, to a fixed fee of US$10,000 per month.

DISC: I hold

@Nerdag, thanks for your Straw. 

I think the announcement highlights profitability and scalability issues. They have churned through cash once again with customer receipts far too low for my liking. I forecasted that this quarterly would be positive, with all signs pointing to ramped up production for Abiomed. I was wrong - revenue went backwards! 

Given cash burn rates, a capital raise is once again around the corner. Can you imagine the discount the company will have to offer potential investors to attract interest and raise enough capital? I am not sticking around to find out. 

This was always a speculative move on my behalf, but the turnaround hasn't occured - in fact business operations have declined - and with NanoDX pulling the pin, the risk far outweighs the reward in my opinion. 

DISC - SOLD 

Back in May, Sensera was told they aren't showing enough evidence that their listing on the ASX is warranted. Fair enough.

So from my surface level reading it seems the stock is suspended indefinitely (or such time they can act in accordance to 12.1 blah blah blah....)

But a couple of days after that announcement I noticed that Capital H Management added another 20% to their holding. Interested by this as I know Harley Grosser has a good eye for smaller companies. Nothing crazy, just worth noting.

Worth flagging on here that there is an AGM at 10:30am Melbourne time on Wednesday 9 November 2022. They note very little about anything other than going through some financial reports and re-electing some directors.

Would be great to pester them about what is keeping the company suspended from trading as I've been unfortunately tied up in this company with no way out since May 2022 and would probably like to rinse my hands and move on. Perhaps this re-elected director can buy my shares on a pink sheet.

No idea what is going on here.

Sensor site says they've sold to ABiomed, ABiomed says they are being acquired by Johnson & Johnson...

No news anywhere accessible to me that would give an indication as to how I can reclaim my small parcel of funds invested in this "business"